Michael S Simon Selected Research

Dietary Fats (Dietary Fat)

1/2021	Low-fat dietary pattern and breast cancer mortality by metabolic syndrome components: a secondary analysis of the Women's Health Initiative (WHI) randomised trial.
10/2018	Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trial.
9/2017	Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled Trial.
8/2017	Interaction between Nonsteroidal Anti-inflammatory Drugs and Low-fat Dietary Intervention on Colorectal Cancer Incidence; the Women's Health Initiative (WHI) Dietary Modification Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael S Simon Research Topics

Disease

62	Breast Neoplasms (Breast Cancer) 05/2024 - 01/2002
40	Neoplasms (Cancer) 05/2024 - 01/2002
7	Colorectal Neoplasms (Colorectal Cancer) 09/2019 - 01/2012
4	Hypertension (High Blood Pressure) 05/2024 - 01/2021
4	Obesity 09/2023 - 01/2018
4	Peripheral Nervous System Diseases (PNS Diseases) 05/2023 - 01/2019
3	Pain (Aches) 05/2023 - 06/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 11/2013
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2018
2	Body Weight (Weight, Body) 10/2023 - 01/2002
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2018
2	Arthralgia (Joint Pain) 11/2018 - 06/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2012
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 02/2016
1	Heart Failure 09/2023
1	Prostatic Neoplasms (Prostate Cancer) 05/2023
1	Hypesthesia (Numbness) 05/2023
1	Liver Neoplasms (Liver Cancer) 01/2023
1	Liver Diseases (Liver Disease) 01/2023
1	Carcinogenesis 01/2018
1	Endometrial Neoplasms (Endometrial Cancer) 01/2018
1	Insulin Resistance 01/2018
1	Breast Carcinoma In Situ 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016
1	Lymphoma (Lymphomas) 02/2016
1	Leukemia 02/2016
1	Polyps 09/2015
1	Lung Neoplasms (Lung Cancer) 07/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2015
1	Myocardial Infarction 11/2013
1	Chronic Disease (Chronic Diseases) 10/2013
1	Melanoma (Melanoma, Malignant) 10/2012
1	Triple Negative Breast Neoplasms 05/2011
1	Migraine Disorders (Migraine) 07/2009

Drug/Important Bio-Agent (IBA)

27	Hormones (Hormone)IBA 05/2024 - 12/2003
19	Estrogen ReceptorsIBA 05/2024 - 11/2003
17	Contraceptive Agents (Contraceptives)IBA 01/2017 - 12/2002
16	Estrogens (Estrogen)FDA Link 01/2020 - 12/2002
15	Progesterone Receptors (Progesterone Receptor)IBA 05/2024 - 11/2003
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2010
10	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2019 - 01/2012
9	Progestins (Progestagens)IBA 01/2020 - 12/2002
8	Oral ContraceptivesIBA 04/2012 - 05/2002
6	CholesterolIBA 05/2024 - 10/2013
5	ORALIT (ORS)IBA 01/2020 - 12/2002
4	Tamoxifen FDA LinkGeneric 03/2023 - 12/2003
4	Dietary Fats (Dietary Fat)IBA 01/2021 - 08/2017
4	human ERBB2 proteinIBA 01/2018 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2012
2	LipidsIBA 01/2023 - 01/2012
2	taxaneIBA 10/2021 - 01/2019
2	Gonadal Steroid Hormones (Sex Hormones)IBA 10/2013 - 12/2004
2	Phenobarbital (Luminal)FDA Link 05/2013 - 01/2010
2	ParaffinIBA 05/2013 - 01/2013
2	Coenzyme A (CoA)IBA 10/2012 - 01/2012
2	Aromatase InhibitorsIBA 12/2003 - 01/2002
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2023
1	oxidized low density lipoproteinIBA 01/2023
1	SugarsIBA 01/2023
1	P 11 (P-11)IBA 01/2020
1	Anticarcinogenic AgentsIBA 09/2019
1	Platinum Compounds (Compounds, Platinum)IBA 01/2019
1	CytokinesIBA 01/2018
1	PhosphoproteinsIBA 01/2018
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2017
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 01/2017
1	Indicators and Reagents (Reagents)IBA 11/2016
1	MicronutrientsIBA 02/2015
1	AntioxidantsIBA 02/2015
1	Methyltestosterone (Oreton)FDA Link 09/2014
1	Testosterone (Sustanon)FDA Link 09/2014
1	estrone sulfate (Evex)FDA Link 10/2013
1	Estradiol (Delestrogen)FDA LinkGeneric 10/2013
1	Estrone FDA Link 10/2013
1	Metformin (Glucophage)FDA LinkGeneric 10/2013
1	Formaldehyde (Formol)FDA Link 01/2013
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 05/2012
1	Amino Acids FDA Link 01/2012
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2012
1	CarbohydratesIBA 01/2011
1	Blood Glucose (Blood Sugar)IBA 01/2011
1	Insulin (Novolin)FDA Link 01/2011
1	Raloxifene Hydrochloride (Evista)FDA Link 12/2007

Therapy/Procedure

25	Therapeutics 09/2023 - 01/2002
5	Hormone Replacement Therapy (Therapy, Hormone Replacement) 05/2004 - 12/2002
4	Drug Therapy (Chemotherapy) 05/2023 - 01/2019
3	Diet Therapy (Therapy, Diet) 01/2021 - 08/2017
3	Hysterectomy 01/2020 - 01/2011
2	Fat-Restricted Diet (Diet, Fat Restricted) 08/2017 - 01/2002
1	Precision Medicine 01/2023
1	Aftercare (After-Treatment) 10/2021
1	Chemoprevention 10/2013
1	Treatment Delay 01/2012
1	Adjuvant Chemotherapy 01/2012
1	Ovariectomy (Oophorectomy) 01/2011
1	Tubal Sterilization (Tubal Ligation) 01/2011